Beyond Drug Development
Beyond is a privately owned product development and early phase CRO, supporting small to medium biotech and pharmaceutical companies across the globe. Our support and advice begin in the pre-clinical…
Services
- Medical Writing
- Product Development
- Global Regulatory Support
- Toxicology Consulting
Overview
Beyond is a privately owned product development and early phase CRO, supporting small to medium biotech and pharmaceutical companies across the globe.
Our support and advice begin in the pre-clinical phase with our in-house toxicologist, who assists our clients in developing protocols for animal studies, performing gap analysis of existing packages ensuring appropriateness of tox and non-clinical packages to support the clinical stage relative to the indication.
We can then support the transition from nonclinical into our clients’ early phase study design, clinical strategy and feasibility, and the expert management of early phase trials within the Australian region through strong relationships with key stakeholders in early phase research. This is underpinned by ongoing regulatory advice and support providing the foundation of our unique offering all the while with a tailored approach to meet our clients’ needs and expectations.